- Filed
- Jul 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Jul 8, 2025 | 128.57M sh |
| Shares Diluted | FY 2025 · Mar 31, 2025 | 73.93M sh |
| Shares Diluted | FY 2025 · Mar 31, 2024 | 67.95M sh |
| Operating Cash Flow | FY 2025 · Mar 31, 2025 | −$68.75K |
| Operating Cash Flow | FY 2025 · Mar 31, 2024 | −$27.67K |
| Cash And Equivalents | FY 2025 · Mar 31, 2025 | $0 |
| Cash And Equivalents | FY 2025 · Mar 31, 2024 | $213 |
| Cash And Equivalents | FY 2025 · Mar 31, 2023 | $7.64K |
| Stockholders Equity | FY 2025 · Mar 31, 2025 | −$1.01M |
| Stockholders Equity | FY 2025 · Mar 31, 2024 | −$1.83M |
| Current Liabilities | FY 2025 · Mar 31, 2025 | $1.04M |
| Current Liabilities restated | FY 2025 · Mar 31, 2024 | $1.87M |
| Total Liabilities | FY 2025 · Mar 31, 2025 | $1.12M |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $1.95M |
| Current Assets | FY 2025 · Mar 31, 2025 | $12.46K |
| Current Assets | FY 2025 · Mar 31, 2024 | $24.36K |
| Total Assets | FY 2025 · Mar 31, 2025 | $102.72K |
| Total Assets | FY 2025 · Mar 31, 2024 | $114.61K |
| Eps Diluted | FY 2025 · Mar 31, 2025 | $0.00 |
| Eps Diluted | FY 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | FY 2025 · Mar 31, 2025 | $18.85K |
| Sga Expense | FY 2025 · Mar 31, 2024 | $41.54K |
| Net Income | FY 2025 · Mar 31, 2025 | −$34.49K |
| Net Income | FY 2025 · Mar 31, 2024 | −$148.43K |
| Operating Income | FY 2025 · Mar 31, 2025 | −$103.33K |
| Operating Income restated | FY 2025 · Mar 31, 2024 | −$114.94K |
| Gross Profit | FY 2025 · Mar 31, 2025 | $22K |
| Gross Profit | FY 2025 · Mar 31, 2024 | $66.98K |
| Cost Of Revenue | FY 2025 · Mar 31, 2025 | $4.38K |
| Cost Of Revenue | FY 2025 · Mar 31, 2024 | $99.31K |
| Revenue | FY 2025 · Mar 31, 2025 | $26.38K |
| Revenue | FY 2025 · Mar 31, 2024 | $166.29K |